Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Statera Biopharma, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q1 2021
- Shares held
- 787.5K
- −280.6K (−26.3%) vs. Q1 2021
- Total value
- $4.31M
- −$1.30M (−23.2%) vs. Q1 2021
- New holders
- 3
- 4 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $1 |
| Q1 2024 | 1 | $1 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 1 | $0 |
| Q2 2023 | 1 | $30 |
| Q1 2023 | 4 | $3.29K |
| Q4 2022 | 29 | $197.5K |
| Q3 2022 | 35 | $383.3K |
| Q2 2022 | 35 | $894.9K |
| Q1 2022 | 33 | $669.2K |
| Q4 2021 | 29 | $4.64M |
| Q3 2021 | 23 | $2.81M |
| Q2 2021 | 21 | $4.31M |
| Q1 2021 | 22 | $5.61M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Statera Biopharma, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 400,080 | $2.19M | 0.47% | −78,861−16.5% | Reduced |
| Renaissance Technologies LLC | 98,051 | $536.0K | 0.00% | −32,500−24.9% | Reduced |
| Vanguard Group Inc | 97,535 | $533.0K | 0.00% | +29,443+43.2% | Added |
| Geode Capital Management, LLC | 63,222 | $345.0K | 0.00% | +18,748+42.2% | Added |
| Cambridge Investment Research Advisors, Inc. | 48,725 | $267.0K | 0.00% | +12,700+35.3% | Added |
| Susquehanna International Group, LLP | 23,995 | $131.0K | 0.00% | +23,995 | New |
| BlackRock Inc. | 19,007 | $104.0K | 0.00% | +18,266+2,465.0% | Added |
| Sequoia Financial Advisors, LLC | 12,588 | $69.0K | 0.00% | +12,588 | New |
| Northern Trust Corp | 11,538 | $63.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,500 | $36.0K | 0.00% | −210,790−97.0% | Reduced |
| Royal Bank of Canada | 3,620 | $20.0K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 438 | $2.00K | 0.00% | 00.0% | Unchanged |
| Archer Investment Corp | 300 | $1.64K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 151 | $1.00K | 0.00% | −486−76.3% | Reduced |
| IFP Advisors, Inc | 150 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 290 | $1.00K | 0.00% | 00.0% | Unchanged |
| FourThought Financial, LLC | 125 | $1.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 100 | $1.00K | 0.00% | +100 | New |
| Wells Fargo & Company | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Orion Capital Management LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| ARS Investment Partners, LLC | 0 | $0 | 0.00% | −36,981−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −36,626−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −31−100.0% | Sold out |